Prostaglandin E2 curtails interleukin-2-dependent effector expansion from tumor-infiltrating stem-like CD8+T cells to promote cancer immune escape

被引：0
|
作者：
Lacher, S. [1 ]
Doerr, J. [2 ]
Almeida, G. [3 ]
Hoenninger, J. [1 ,4 ]
Meiser, P. [1 ]
Bayerl, F. [1 ]
Pedde, A. [1 ]
Hirschberger, A. [1 ]
Jarosch, S. [4 ,7 ]
Gregor, L. [2 ]
Busch, D. [4 ]
Buchholz, V. [4 ]
Knolle, P. [1 ]
Zehn, D. [3 ]
Kobold, S. [2 ,5 ,6 ]
Boettcher, J. [1 ]
机构：
[1] TUM, Inst Mol Immunol, Sch Med, Munich, Germany
[2] LMU, Klinikum Univ Munchen, German Ctr Lung Res DZL, Div Clin Pharmacol,Dept Med 4, Munich, Germany
[3] TUM, Sch Life Sci Weihenstephan, Div Anim Physiol & Immunol, Freising Weihenstephan, Germany
[4] TUM, Sch Med, Inst Med Microbiol Immunol & Hyg, Munich, Germany
[5] German Ctr Translat Canc Res DKTK, Partner Site Munich, Munich, Germany
[6] Helmholtz Munich, Res Ctr Environm Hlth HMGU, Einheit Klin Pharmakol EKLiP, Munich, Germany
[7] 15 Boehringer Ingelheim Pharma GmbH & Co KG, Biberach, Germany
来源：
EUROPEAN JOURNAL OF IMMUNOLOGY | 2023年 / 53卷
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
O17
引用
收藏
页码：50 / 50
页数：1
相关论文
共 50 条
  • [41] Expansion of circulating stem-like CD8+ T cells by adding CD122-directed IL-2 complexes to radiation and anti-PD1 therapies in mice (14, 2087, 2023)
    Onyshchenko, Kateryna
    Luo, Ren
    Guffart, Elena
    Gaedicke, Simone
    Grosu, Anca-Ligia
    Firat, Elke
    Niedermann, Gabriele
    NATURE COMMUNICATIONS, 2024, 15 (01)
  • [42] Tumor NOS2 and COX2 Spatial Juxtaposition with CD8+ T Cells Promote Metastatic and Cancer Stem Cell Niches that Lead to Poor Outcome in ER- Breast Cancer
    Ridnour, Lisa A.
    Heinz, William F.
    Cheng, Robert Y. S.
    Wink, Adelaide L.
    Kedei, Noemi
    Pore, Milind
    Imtiaz, Fatima
    Femino, Elise L.
    Gonzalez, Ana L.
    Coutinho, Leandro L.
    Moffat, Rebecca L.
    Butcher, Donna
    Edmondson, Elijah F.
    Li, Xiaoxian
    Rangel, Maria Cristina
    Kinders, Robert J.
    Rittscher, Jens
    Lipkowitz, Stanley
    Wong, Stephen T. C.
    Anderson, Stephen K.
    Mcvicar, Daniel W.
    Glynn, Sharon A.
    Billiar, Timothy R.
    Chang, Jenny C.
    Hewitt, Stephen M.
    Ambs, Stefan
    Lockett, Stephen J.
    Wink, David A.
    CANCER RESEARCH COMMUNICATIONS, 2024, 4 (10): : 2766 - 2782
  • [43] Regulation of TCR-induced IFN-γ release from islet-reactive non-obese diabetic CD8+ T cells by prostaglandin E2 receptor signaling
    Ganapathy, V
    Gurlo, T
    Jarstadmarken, HO
    von Grafenstein, H
    INTERNATIONAL IMMUNOLOGY, 2000, 12 (06) : 851 - 860
  • [44] Type 1 and type 2 CD8 effector cells promote long-term tumor immunity through different mechanisms that are subsequently dependent on host-derived type 1 immune responses.
    Dobrzanski, MJ
    Reome, JB
    Dutton, RW
    FASEB JOURNAL, 2002, 16 (04) : A337 - A337
  • [45] CD8-Targeted PET Imaging of Tumor-Infiltrating T Cells in Patients with Cancer: A Phase I First-in-Humans Study of 89Zr-Df-IAB22M2C, a Radiolabeled Anti-CD8 Minibody
    Farwell, Michael D.
    Gamache, Raymond F.
    Babazada, Hasan
    Hellmann, Matthew D.
    Harding, James J.
    Korn, Ron
    Mascioni, Alessandro
    Le, William
    Wilson, Ian
    Gordon, Michael S.
    Wu, Anna M.
    Ulaner, Gary A.
    Wolchok, Jedd D.
    Postow, Michael A.
    Pandit-Taskar, Neeta
    JOURNAL OF NUCLEAR MEDICINE, 2022, 63 (05) : 720 - 726
  • [46] GLP1 alleviates oleic acid-propelled lipocalin-2 generation by tumor-infiltrating CD8+ T cells to reduce polymorphonuclear MDSC recruitment and enhances viral immunotherapy in pancreatic cancer
    Wu, Jingyi
    Qian, Peng
    Han, Yifeng
    Xu, Chuning
    Xia, Mao
    Zhan, Ping
    Wei, Jiwu
    Dong, Jie
    CELLULAR & MOLECULAR IMMUNOLOGY, 2025, 22 (03) : 282 - 299
  • [47] Type 1 and type 2 CD8 effector cell immunotherapy induce long-term tumor immunity and elicit endogenous tetramer-positive CD8 memory T cells associated with type 1-like immune responses
    Dobrzanski, MJ
    Reome, JB
    Dutton, R
    FASEB JOURNAL, 2003, 17 (07) : C76 - C77
  • [48] Mesenchymal stem cells suppress CD8+ T cell-mediated activation by suppressing natural killer group 2, member D protein receptor expression and secretion of prostaglandin E2, indoleamine 2, 3-dioxygenase and transforming growth factor-β
    Li, Mingfen
    Sun, Xuyong
    Kuang, Xiaocong
    Liao, Yan
    Li, Haibin
    Luo, Dianzhong
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2014, 178 (03) : 516 - 524
  • [49] Antigen presentation of the Oct4 and Sox2 peptides by CD154-activated B lymphocytes enhances the killing effect of cytotoxic T lymphocytes on tumor stem-like cells derived from cisplatin-resistant lung cancer cells
    Zhang, Xueyan
    Zhang, Yanwei
    Xu, Jianlin
    Wang, Huimin
    Zheng, Xiaoxuan
    Lou, Yuqing
    Han, Baohui
    JOURNAL OF CANCER, 2018, 9 (02): : 367 - 374
  • [50] HIGH ENDOTHELIAL VENULES CONTROL THE JOURNEY OF STEM-LIKE CD8+ T CELLS FROM LYMPH NODE TO TUMOR DURING CANCER IMMUNOTHERAPY WITH COMBINED ANTI-PD-1 PLUS ANTI-CTLA-4 ANTIBODIES
    Blanchard, Lucas
    Vina, Estefania
    Tarroux, Dorian
    Lefrancais, Emma
    Ortega, Nathalie
    Girard, Jean-Philippe
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2022, 10 : A530 - A530
12345